Epilepsy is a common disorder but diagnosis remains largely clinical. Although MRI and EEG significantly aid the diagnosis of epilepsy, these techniques may also be misleading and indicate abnormalities not related to phenomenology. Consequences of erroneous diagnosis of epilepsy may lead to aggressive and escalating pharmacotherapy with potentially serious side effects. Metabolic disorders, which may mimic epilepsy, should always be considered as they are potentially curable and may be fatal if untreated. We report a case of an insulinoma, misdiagnosed as temporal lobe epilepsy. We highlight the risks associated with misinterpretation of neuroimaging and EEG and outline an approach to differentiate between symptoms of insulinoma or neuroglycopenia and temporal epileptic seizures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1684/epd.2013.0556 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Case of Type 2 Diabetes Mellitus Revealed Transient Positivity of Glutamic Acid Decarboxylase (GAD) Antibodies Following Immunoglobulin Administrations.
Cureus
August 2024
Department of Neurology, Hiroshima City North Medical Center Asa Citizens Hospital, Hiroshima, JPN.
Glutamic acid decarboxylase (GAD) antibodies are frequently measured in diabetes care as islet-associated autoantibodies that are useful in the diagnosis of type 1 diabetes. However, GAD antibodies derived from other persons may contaminate immunoglobulin preparations, and there have been cases of transiently positive GAD antibodies after intravenous immunoglobulin (IVIg) in patients who were originally negative for GAD antibodies. Clinicians may be unaware of such contamination and misdiagnose some cases as type 1 instead of type 2 diabetes mellitus based on positivity for GAD antibodies.
View Article and Find Full Text PDFA case of insulinoma misidentified as schizophrenia due to its manifestation in neuropsychiatric symptoms.
Diabetol Int
July 2024
Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School, 1-1 Yanagido, Gifu, 501-1194 Japan.
Unlabelled: Insulinomas can present with neuroglycopenic symptoms suggesting neuropsychiatric disorders, delaying diagnosis and treatment. We recently treated a 65-year-old woman with insulinoma who was misdiagnosed at her nearby psychiatric clinic as having schizophrenia because of personality changes and memory impairment; she was treated with brexpiprazole, which was discontinued due to persistence of the symptoms. Despite her relatively low casual plasma glucose (70 mg/dL), the physician at the psychiatric clinic did not investigate the possibility of hypoglycemia, partly because her HbA1c level (5.
View Article and Find Full Text PDFHypoglycemia in non-diabetic in-patients at a teaching referral hospital in Iran.
J Diabetes Metab Disord
June 2024
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Article Synopsis
- This study examined non-diabetic patients with hypoglycemia to understand their comorbid conditions, symptoms, lab results, and diagnoses.
- Conducted at Shariati Hospital in Iran from 2016 to 2023, it analyzed data from 74 non-diabetic patients, excluding those with diabetes and focusing on various factors related to their hypoglycemic episodes.
- The findings revealed that a significant portion experienced common symptoms like weakness and dizziness, with underlying causes including psychological disorders and organ failure, highlighting the need for timely diagnosis and treatment to avoid serious health consequences.
Insulinoma-Associated Protein-1 Expression in Lymphoepithelial Carcinoma of the Thymus: A Potential Pitfall for Diagnosis With Neuroendocrine Carcinomas of the Thymus.
Arch Pathol Lab Med
June 2024
From the Department of Pathology, Rutgers University, New Jersey Medical School, Newark (DI Suster, S Suster).
Context.—: Insulinoma-associated protein-1 (INSM1) is a recently developed immunohistochemical marker claimed to be highly specific and sensitive for the diagnosis of neuroendocrine malignancies. Recent studies, however, have demonstrated that this marker can also be expressed in non-neuroendocrine neoplasms including squamous cell carcinoma of the thymus.
View Article and Find Full Text PDFCase report: Insulinoma masquerades as epilepsy - quantitative EEG analysis.
Front Neurol
March 2024
First Department of Neurology, St. Anne's University Hospital Brno, Masaryk University, Member of the ERN EpiCARE, Brno, Czechia.
Insulinomas are rare gastrointestinal tumors with an incidence of 1-3 per million inhabitants annually. These tumors result in excessive insulin production, culminating in hypoglycemia. Such hypoglycemia triggers various central nervous system (CNS) manifestations, including headache, confusion, abnormal behavior, and epileptic seizures, which can lead to misdiagnosis as epilepsy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!